睡眠時ブラキシズム治療の世界市場予測...市場調査レポートについてご紹介

Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Assumptions & Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Data Triangulation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing prevalence of sleep bruxism
4.2.2 Growing child population
4.2.3 Rising prevalence of obstructive sleep apnea
4.2.4 Lifestyle changes
4.2.5 Drivers Impact Analysis
4.3 Restraints
4.3.1 Limited availability of treatment options
4.3.2 High cost of custom fit night guards
4.3.3 Restraints Impact Analysis
4.4 Opportunity
4.4.1 Untapped markets of the Asia Pacific region
4.5 Macroeconomic Indicator
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D and Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Review
 
5.2 Porter’s Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
6 Global Sleeping Bruxism Treatment Market, by Type
6.1 Introduction
6.2 Primary Bruxism
6.3 Secondary Bruxism
7 Global Sleeping Bruxism Treatment Market, by Diagnosis
7.1 Introduction
7.1.1 Clinical Examination
7.1.2 X-rays
7.1.3 Electromyographic Methods
7.1.4 Polysomnography
8 Global Sleeping Bruxism Treatment Market, by Treatment Type
8.1 Introduction
8.2 Dental Approaches
8.3 Medication
9 Global Sleeping Bruxism Treatment Market, by Cause
9.1 Introduction
9.2 Obstructive Sleep Apnea
9.3 Gastroesophageal reflux disease (GERD)
9.4 Malocclusion
9.5 Sleep Paralysis
10 Global Sleeping Bruxism Treatment Market, by Patient Type
10.1 Introduction
10.2 Pediatric
10.3 Adult
11 Global Sleeping Bruxism Treatment Market, by End-User
11.1 Introduction
11.2 Hospitals
11.3 Dental Clinics
12 Global Sleeping Bruxism Treatment Market, by Region
12.1 Introduction
12.2 Americas
12.2.1 North America
12.2.1.1 US
12.2.1.2 Canada
12.2.2 South America
12.3 Europe
12.3.1 Introduction
12.3.2 Western Europe
12.3.2.1 Germany
12.3.2.2 France
12.3.2.3 U.K
12.3.2.4 Scandinavia
12.3.2.4.1 Denmark
12.3.2.4.2 Norway
12.3.2.4.3 Sweden
12.3.2.4.4 Finland
12.3.2.4.5 Iceland
12.3.2.5 Benelux Union
12.3.2.5.1 Belgium
12.3.2.5.2 Netherlands
12.3.2.5.3 Luxembourg
12.3.2.6 Italy
12.3.2.7 Spain
12.3.2.8 Switzerland
12.3.3 Eastern Europe
12.4 Asia Pacific
12.4.1 Introduction
12.4.2 China
12.4.3 India
12.4.4 Japan
12.4.5 South Korea
12.4.6 Rest of Asia Pacific
12.5 Middle East & Africa
12.5.1 Introduction
12.5.2 Middle East
12.5.3 Africa
13 Competitive Analysis
13.1 Introduction
14 Company Profiles
14.1 Ivoclar Vivadent AG
14.1.1 Company Overview
14.1.2 Financial Overview
14.1.3 Products Offering
14.1.4 Key Developments
14.1.5 SWOT Analysis
14.1.6 Key Strategy
14.2 Ipsen Biopharmaceuticals, Inc.
14.2.1 Company Overview
14.2.2 Financial Overview
14.2.3 Products Offering
14.2.4 Key Developments
14.2.5 SWOT Analysis
14.2.6 Key Strategy
14.3 Merz Pharma GmbH & Co. KGaA
14.3.1 Company Overview
14.3.2 Financial Overview
14.3.3 Products Offering
14.3.4 Key Developments
14.3.5 SWOT Analysis
14.3.6 Key Strategy
14.4 Carestream Dental
14.4.1 Company Overview
14.4.2 Financial Overview
14.4.3 Products Offering
14.4.4 Key Developments
14.4.5 SWOT Analysis
14.4.6 Key Strategy
14.5 Akervall Technologies Inc.
14.5.1 Company Overview
14.5.2 Financial Overview
14.5.3 Products Offering
14.5.4 Key Developments
14.5.5 SWOT Analysis
14.5.6 Key Strategy
14.6 PLANMECA OY
14.6.1 Company Overview
14.6.2 Financial Overview
14.6.3 Products Offering
14.6.4 Key Developments
14.6.5 SWOT Analysis
14.6.6 Key Strategy
14.7 Randmark Dental Products, LLC
14.7.1 Company Overview
14.7.2 Financial Overview
14.7.3 Products Offering
14.7.4 Key Developments
14.7.5 SWOT Analysis
14.7.6 Key Strategy
14.8 S4S Dental Laboratory
14.8.1 Company Overview
14.8.2 Financial Overview
14.8.3 Products Offering
14.8.4 Key Developments
14.8.5 SWOT Analysis
14.8.6 Key Strategy
14.9 Patterson Dental Supply, Inc.
14.9.1 Company Overview
14.9.2 Financial Overview
14.9.3 Products Offering
14.9.4 Key Developments
14.9.5 SWOT Analysis
14.9.6 Key Strategy
14.1 Henry Schein, Inc.
14.10.1 Company Overview
14.10.2 Financial Overview
14.10.3 Products Offering
14.10.4 Key Developments
14.10.5 SWOT Analysis
14.10.6 Key Strategy
14.11 Pfizer Inc.
14.11.1 Company Overview
14.11.2 Financial Overview
14.11.3 Products Offering
14.11.4 Key Developments
14.11.5 SWOT Analysis
14.11.6 Key Strategy
15 Appendix
15.1 Discussion Blue Print